CRP and metabolic syndrome: We then examined whether the possible protective effect of haplogroup H1 towards T2DM was related to age, gender, obesity, smoking, and/or to some clinical traits such as BMI, metabolic syndrome, insulin resistance, fibrinogen, C-reactive protein, HbA1c, HDL, triglycerides and hypertension.